SCHEMBL26484276

SCHEMBL26484276

N#Cc1cc(F)c2c(c1)CCCC2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ XDH P47989 1/20 0.40
▸ SLC22A12 Q96S37 1/20 0.40
▸ KDM4E B2RXH2 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ HPGD P15428 2/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ APOBEC3G Q9HC16 1/20 0.39
▸ CYP11B2 P19099 3/20 0.38
▸ ALOX15 P16050 1/20 0.38
▸ ALOX12 P18054 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ DRD2 P14416 2/20 0.37
▸ DRD3 P35462 2/20 0.37
▸ PNMT P11086 1/20 0.37
▸ HSD11B1 P28845 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ PARP1 P09874 1/20 0.34
▸ CYP11B1 P15538 2/20 0.33
▸ TRPV4 Q9HBA0 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19679244 0.81 XDH (0.49) XDHSLC22A12KDM4EALDH1A1MAPT
SCHEMBL11818698 0.81 KDM4E (0.32) KDM4ENPSR1
SCHEMBL24265339 0.78 PNMT (0.54) DRD2DRD3PNMT
SCHEMBL6228564 0.77 MEN1 (0.45) XDHSLC22A12KDM4EALDH1A1MAPT
SCHEMBL24266504 0.75 HTR7 (0.37) XDHSLC22A12KDM4ENPSR1CYP11B2
SCHEMBL31158962 0.73 PNMT (0.44) ALDH1A1DRD2DRD3PNMTTRPV4
SCHEMBL4263061 0.73 MEN1 (0.45) XDHSLC22A12KDM4EALDH1A1MAPT
SCHEMBL25121131 0.73 DRD2 (0.42) KDM4EALDH1A1HPGDHSD17B10DRD2
SCHEMBL11812218 0.73 XDH (0.33) XDHSLC22A12KDM4EALDH1A1HPGD
SCHEMBL7792883 0.73 MAOA (0.33) PARP1CXCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230322744-A1 COMPOUNDS AS GLP-1R AGONISTS TERNS PHARMACEUTICALS, INC. 2023-10-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230322744-A1 COMPOUNDS AS GLP-1R AGONISTS GLP1R, GIPR, GCGR XDH 1788/4885SLC22A12 2614/4885KDM4E 4574/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback